F‐18 FDG PET‐CT fusion in radiotherapy treatment planning for head and neck cancer

The fusion of fluoro‐2‐deoxy‐d‐glucose–positron emission tomography (FDG‐PET) with CT scans has been shown to improve diagnostic accuracy and staging in non‐small cell lung cancer. We report on the influence of PET‐CT fusion on the management of patients with head and neck cancer.

[1]  R. Coleman,et al.  Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies. , 2002, The Annals of thoracic surgery.

[2]  Mithat Gonen,et al.  Diagnostic and Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma , 2002 .

[3]  G J Kutcher,et al.  The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  A. Buck,et al.  Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Yu Chi Hu,et al.  Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  M. Schwaiger,et al.  Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting. , 1999, Archives of otolaryngology--head & neck surgery.

[7]  S. Larson,et al.  Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Thomas F Hany,et al.  Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment. , 2002, AJR. American journal of roentgenology.

[9]  A. Garden,et al.  Can positron emission tomography improve the quality of care for head-and-neck cancer patients? , 2001, International journal of radiation oncology, biology, physics.

[10]  V Kalff,et al.  Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Alavi,et al.  Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck , 1999, European Journal of Nuclear Medicine.

[12]  G. V. von Schulthess,et al.  Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. , 2003, Oral oncology.

[13]  G. Hör,et al.  Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer , 1998, European Journal of Nuclear Medicine.

[14]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[15]  Gerald J. Kutcher,et al.  The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer , 2000 .

[16]  John L. Humm,et al.  Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  B C Stack,et al.  Surveillance for recurrent head and neck cancer using positron emission tomography. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  K Schnabel,et al.  18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. , 1999, International journal of radiation oncology, biology, physics.

[19]  M. Spieth,et al.  A tabulated summary of the FDG PET literature. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  Curtis B Caldwell,et al.  The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. , 2002, International journal of radiation oncology, biology, physics.

[21]  L. Peters,et al.  The usefulness of fluorine 18–labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor , 2003, Head & neck.

[22]  B. Nowak,et al.  Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. , 2000, Archives of otolaryngology--head & neck surgery.

[23]  Merence Sibomana,et al.  Impact of image coregistration with computed tomography (CT), magnetic resonance (MR) and positron emission tomography with fluorodeoxyglucose (FDG-PET) on delineation of GTV’s in oropharyngeal, laryngeal and hypopharyngeal tumors , 2002 .

[24]  C B Caldwell,et al.  Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. , 2001, International journal of radiation oncology, biology, physics.

[25]  M. Wax,et al.  Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer. , 2002, Archives of otolaryngology--head & neck surgery.

[26]  S U Berlangieri,et al.  The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. , 1998, Lung cancer.

[27]  K. Geisinger,et al.  A comparative diagnostic study of head and neck nodal metastases using positron emission tomography , 1995, The Laryngoscope.

[28]  Wade L Thorstad,et al.  Role of fusion in radiotherapy treatment planning. , 2003, Seminars in nuclear medicine.

[29]  Tohru Shiga,et al.  Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. , 2002, International journal of radiation oncology, biology, physics.

[30]  P. V. van Rijk,et al.  18F‐fluorodeoxyglucose dual‐head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer , 1999, Cancer.

[31]  H. Baddeley,et al.  A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. , 1997, Clinical otolaryngology and allied sciences.